Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Enaltus (US rights to BioCorneum)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Rights of a pharmaceutical product. The asset includes distribution rights for BioCorneum, an advanced silicone gel scar management products of the company Enaltus in the United States. The product is a quick drying, patented silicone gel that creates an invisible, breathable, flexible, and waterproof silicone sheet over scars.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • United States

Enaltus (US rights to BioCorneum) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Enaltus (US rights to BioCorneum)‘s full profile, request access.

Request full access to PitchBook

Enaltus (US rights to BioCorneum) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Enaltus (US rights to BioCorneum)‘s full profile, request access.

Request full access to PitchBook